EA200300126A1 - Ранняя диагностика конформационных заболеваний - Google Patents

Ранняя диагностика конформационных заболеваний

Info

Publication number
EA200300126A1
EA200300126A1 EA200300126A EA200300126A EA200300126A1 EA 200300126 A1 EA200300126 A1 EA 200300126A1 EA 200300126 A EA200300126 A EA 200300126A EA 200300126 A EA200300126 A EA 200300126A EA 200300126 A1 EA200300126 A1 EA 200300126A1
Authority
EA
Eurasian Patent Office
Prior art keywords
diseases
conformational diseases
early diagnostics
conformational
pathogenic conformer
Prior art date
Application number
EA200300126A
Other languages
English (en)
Other versions
EA007391B1 (ru
Inventor
Клаудио Сото
Габриэлла Саборио
Original Assignee
Апплайд Резеч Системз Арс Холдинг Н.В.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Апплайд Резеч Системз Арс Холдинг Н.В. filed Critical Апплайд Резеч Системз Арс Холдинг Н.В.
Publication of EA200300126A1 publication Critical patent/EA200300126A1/ru
Publication of EA007391B1 publication Critical patent/EA007391B1/ru

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2828—Prion diseases

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Описан способ диагностики или выявления конформационных заболеваний путем анализа образца на наличие маркера (патогенный конформер) указанных заболеваний; способ включает в себя систему циклической амплификации для повышения уровней патогенного конформера, который вызывает указанные заболевания. В частности, указанными трансмиссивными конформационными заболеваниями могут быть прионные энцефалопатии. Описаны также анализы, диагностические наборы и аппарат, основанные на указанных способах.Отчет о международном поиске был опубликован 2002.10.24.
EA200300126A 2000-07-07 2001-06-13 Способ диагностики или выявления конформационного заболевания или его маркера и набор для использования в способе EA007391B1 (ru)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP00114650 2000-07-07
EP00127892 2000-12-20
EP01102732 2001-02-07
PCT/GB2001/002584 WO2002004954A2 (en) 2000-07-07 2001-06-13 Early diagnosis of conformational diseases

Publications (2)

Publication Number Publication Date
EA200300126A1 true EA200300126A1 (ru) 2003-06-26
EA007391B1 EA007391B1 (ru) 2006-10-27

Family

ID=27223071

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200300126A EA007391B1 (ru) 2000-07-07 2001-06-13 Способ диагностики или выявления конформационного заболевания или его маркера и набор для использования в способе

Country Status (31)

Country Link
US (1) US7351526B2 (ru)
EP (2) EP1712920B1 (ru)
JP (1) JP4790966B2 (ru)
KR (1) KR100764981B1 (ru)
CN (1) CN1221807C (ru)
AR (1) AR029583A1 (ru)
AT (2) ATE426816T1 (ru)
AU (2) AU2001264089B2 (ru)
BG (1) BG66272B1 (ru)
BR (1) BRPI0112262B8 (ru)
CA (1) CA2413078C (ru)
CY (1) CY1109106T1 (ru)
CZ (1) CZ304365B6 (ru)
DE (2) DE60138146D1 (ru)
DK (2) DK1712920T3 (ru)
EA (1) EA007391B1 (ru)
EE (1) EE05675B1 (ru)
ES (2) ES2322660T3 (ru)
HK (1) HK1058065A1 (ru)
HR (1) HRP20030033B1 (ru)
HU (1) HU228813B1 (ru)
IL (2) IL153824A0 (ru)
MX (1) MXPA03000226A (ru)
NO (1) NO331624B1 (ru)
NZ (1) NZ523213A (ru)
PL (1) PL211154B1 (ru)
PT (2) PT1712920E (ru)
RS (1) RS51523B (ru)
SI (2) SI1299729T1 (ru)
SK (1) SK287768B6 (ru)
WO (1) WO2002004954A2 (ru)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002073210A1 (de) * 2001-03-13 2002-09-19 Manfred Eigen Verfahren zur verstärkung der bildung von aggregaten aus proteinuntereinheiten
JP4235544B2 (ja) 2001-05-31 2009-03-11 アドライフ インコーポレーティッド 欠陥折畳み蛋白質センサー方法
US20050026165A1 (en) 2001-05-31 2005-02-03 Cindy Orser Detection of conformationally altered proteins and prions
CA2525517C (en) 2003-06-19 2016-05-31 Applied Research Systems Ars Holding N.V. Use of prion conversion modulating agents
DE10328125A1 (de) * 2003-06-23 2005-01-13 Roche Diagnostics Gmbh Nachweis von Protease-resistentem Prion-Protein nach spontaner Transformationsreaktion
DE10328830A1 (de) * 2003-06-26 2005-01-20 Roche Diagnostics Gmbh Nachweis von Protease-resistentem Prion-Protein nach asymmetrischer Interaktion
US20070054322A1 (en) * 2003-07-31 2007-03-08 Hadasit Medical Research Services & Development Lt Methods and kits for the detection of prion diseases
EP1653844B1 (en) 2003-08-13 2012-12-12 Novartis Vaccines and Diagnostics, Inc. Prion-specific peptide reagents
US20060057671A1 (en) * 2004-09-10 2006-03-16 Orser Cindy S Immobilized probes and methods of detecting conformationally altered prion proteins
JP4568840B2 (ja) * 2004-12-28 2010-10-27 国立大学法人金沢大学 アルツハイマー病の検査方法
WO2006088823A2 (en) * 2005-02-15 2006-08-24 Adlyfe, Inc. Method for detecting misfolded proteins and prions
WO2006113915A2 (en) * 2005-04-20 2006-10-26 Board Of Regents, The University Of Texas System Ultrasensitive detection of prions by automated protein misfolding cyclic amplification
EP1731911A1 (fr) 2005-06-07 2006-12-13 Institut National De La Sante Et De La Recherche Medicale (Inserm) Procédé utile pour la détection d'encéphalopathies
DE102005031429A1 (de) * 2005-07-04 2007-01-11 Heinrich-Heine-Universität Düsseldorf Verfahren zur selektiven Bestimmung pathologischer Proteinablagerungen
CA2621767A1 (en) 2005-09-09 2007-03-15 Novartis Ag Prion-specific peptoid reagents
US20070281367A1 (en) 2006-05-03 2007-12-06 Applera Corporation Methods, Compositions, and Kits for Quantitating Antibodies
WO2008013859A2 (en) * 2006-07-28 2008-01-31 Adlyfe, Inc. Peptide probes for diagnostics and therapeutics
EP2074222A4 (en) * 2006-09-06 2010-03-03 Univ Texas METHODS AND COMPOSITIONS FOR DETECTION OF PROTEIN FOLDING DISORDERS
EP2554996B1 (en) * 2007-07-20 2016-04-06 THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by the SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES Detection of infectious prion protein by seeded conversion of recombinant prion protein
FR2929290B1 (fr) * 2008-03-27 2010-05-07 Lfb Biotechnologies Methode de detection et/ou de titrage in vitro d'un agent transmissible non conventionnel
US20110124843A1 (en) 2008-05-28 2011-05-26 Incorporated Administrative Agency National Agriculture And Food Research Organization Method for efficiently amplifying abnormal prion protein derived from bse
JP5209711B2 (ja) 2008-05-28 2013-06-12 独立行政法人農業・食品産業技術総合研究機構 羊スクレイピー由来異常プリオン蛋白質の効率的増幅方法
ITMI20081052A1 (it) * 2008-06-10 2009-12-11 Univ Milano Bicocca Liposomi in grado di legare efficacemente il peptide beta-amiloide
FR2935711A1 (fr) * 2008-09-05 2010-03-12 Lfb Biotechnologies Clone cellulaire stable exprimant un prion
JP2013510297A (ja) * 2009-11-04 2013-03-21 ノバルティス アーゲー モノマーからのタンパク質凝集体の分離における結合試薬としての正に荷電した種
US10989718B2 (en) 2014-09-11 2021-04-27 Amprion, Inc. Detection of misfolded alpha synuclein protein
US10215763B2 (en) * 2010-05-18 2019-02-26 Board Of Regents Of The University Of Texas System Methods for estimating prion concentration in fluids and tissue by quantitative PMCA
IT1405762B1 (it) 2010-11-25 2014-01-24 Icgeb Proteine ricombinanti con attivita' di inattivazione selettiva di proteine bersaglio
CA2824863A1 (en) * 2011-01-18 2012-07-26 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Methods for amplification and detection of prions
FR2973114A1 (fr) 2011-03-21 2012-09-28 Ets Francais Du Sang Nanobilles recouvertes de plasminogene comme support direct d'amplification cyclique de la proteine prion prpsc
WO2013056841A1 (en) 2011-10-19 2013-04-25 Inra (Institut National De La Recherche Agronomique) A method for diagnosing tse
KR101483438B1 (ko) * 2014-04-17 2015-01-16 한림대학교 산학협력단 극미량 병원성 프리온 단백질 검출방법 및 장치
WO2016040903A1 (en) 2014-09-11 2016-03-17 Board Of Regents Of The University Of Texas System Detection of misfolded amyloid beta protein
MX2017003269A (es) 2014-09-11 2017-12-04 Univ Texas Detección de las proteínas mal plegadas.
US10359434B2 (en) 2014-10-22 2019-07-23 Colorado State University Research Foundation In vitro detection of prions in blood
WO2016149537A1 (en) 2015-03-17 2016-09-22 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Bank vole prion protein as a broad-spectrum substrate for rt-quic-based detection and discrimination of prion strains
EP3635393A4 (en) 2017-05-16 2021-03-10 Claudio Soto-Jara DETECTION OF MISFOLDED TAU PROTEIN
US20190353669A1 (en) * 2018-05-16 2019-11-21 Amprion, Inc. Detection of Brain Injury or Neurological Disease using Tau Protein
US11598783B1 (en) 2019-10-23 2023-03-07 Colorado State University Research Foundation In vitro detection of prions
WO2021198098A1 (en) 2020-04-03 2021-10-07 Universität Zürich Improved method of detecting biomarkers in a biological sample

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5262332A (en) * 1989-04-05 1993-11-16 Brigham And Women's Hospital Diagnostic method for Alzheimer's disease: examination of non-neural tissue
US5616871A (en) * 1995-09-28 1997-04-01 Drummond Scientific Company Pipet gun assembly
US5750361A (en) * 1995-11-02 1998-05-12 The Regents Of The University Of California Formation and use of prion protein (PRP) complexes
CA2268904A1 (en) * 1996-10-15 1998-04-23 Imperial College Of Science, Technology And Medicine Diagnosis of spongiform encephalopathy
EP1210110A4 (en) * 1999-06-29 2003-03-19 Univ Mcgill PROTEINS BINDING TO PRION PROTEIN AND THEIR USE
CA2393607A1 (en) * 1999-12-10 2001-06-28 Ronald R. Manna Ultrasonic horn assembly
WO2006113915A2 (en) * 2005-04-20 2006-10-26 Board Of Regents, The University Of Texas System Ultrasensitive detection of prions by automated protein misfolding cyclic amplification

Also Published As

Publication number Publication date
BRPI0112262B8 (pt) 2021-07-27
BR0112262A (pt) 2003-05-20
HK1058065A1 (en) 2004-04-30
DE60121958T2 (de) 2007-02-01
HUP0301020A2 (hu) 2003-07-28
CZ200336A3 (cs) 2003-06-18
SK18582002A3 (sk) 2003-05-02
DK1712920T3 (da) 2009-05-11
WO2002004954A3 (en) 2002-10-24
US7351526B2 (en) 2008-04-01
KR100764981B1 (ko) 2007-10-09
DE60138146D1 (de) 2009-05-07
ATE426816T1 (de) 2009-04-15
PT1712920E (pt) 2009-04-09
ES2322660T3 (es) 2009-06-24
IL153824A0 (en) 2003-07-31
KR20030036257A (ko) 2003-05-09
NZ523213A (en) 2005-01-28
MXPA03000226A (es) 2004-05-21
HU228813B1 (en) 2013-05-28
YU101202A (sh) 2006-01-16
CY1109106T1 (el) 2014-07-02
ES2264691T3 (es) 2007-01-16
EE200300005A (et) 2004-08-16
CN1221807C (zh) 2005-10-05
AR029583A1 (es) 2003-07-02
BG66272B1 (bg) 2012-11-30
ATE335204T1 (de) 2006-08-15
DE60121958D1 (de) 2006-09-14
RS51523B (sr) 2011-06-30
BRPI0112262B1 (pt) 2016-08-09
EA007391B1 (ru) 2006-10-27
JP2004503748A (ja) 2004-02-05
HUP0301020A3 (en) 2010-03-29
SI1712920T1 (sl) 2009-10-31
CN1449497A (zh) 2003-10-15
AU2001264089B2 (en) 2006-03-30
WO2002004954A2 (en) 2002-01-17
SI1299729T1 (sl) 2006-10-31
CA2413078C (en) 2010-08-03
NO20030059L (no) 2003-03-07
EE05675B1 (et) 2013-08-15
EP1299729A2 (en) 2003-04-09
DK1299729T3 (da) 2006-12-04
PL360397A1 (en) 2004-09-06
IL153824A (en) 2010-02-17
SK287768B6 (sk) 2011-09-05
PL211154B1 (pl) 2012-04-30
EP1712920B1 (en) 2009-03-25
JP4790966B2 (ja) 2011-10-12
HRP20030033B1 (en) 2008-04-30
EP1299729B1 (en) 2006-08-02
PT1299729E (pt) 2006-10-31
CZ304365B6 (cs) 2014-04-02
US20050064505A1 (en) 2005-03-24
NO20030059D0 (no) 2003-01-06
HRP20030033A2 (en) 2004-02-29
EP1712920A1 (en) 2006-10-18
BG107498A (bg) 2003-11-28
CA2413078A1 (en) 2002-01-17
NO331624B1 (no) 2012-02-06
AU6408901A (en) 2002-01-21

Similar Documents

Publication Publication Date Title
EA200300126A1 (ru) Ранняя диагностика конформационных заболеваний
ATE330024T1 (de) Nachweis von konditionen durch gas- oder dampfanalyse
ATE406578T1 (de) Candida-nachweis
EA200500355A1 (ru) Способ обнаружения, характеристики и мониторинга углеводородных месторождений
WO2021067850A3 (en) METHODS OF DETECTING circRNA
PT1360282E (pt) Metodo de inactivacao da eet
PT946874E (pt) Diagnostico de helicobacter pylori
EA200200435A1 (ru) Анализ лептина
DE60112949D1 (de) Verfahren zum nachweis eines lipoprotein-akutphaseprotein-komplexes
ATE397093T1 (de) Test auf mikroorganismen zur diagnose von sepsis
DE60010301D1 (de) Versuchsanordnung zur diagnose von mastitis durch nachweis von haptoglobin
ATE461452T1 (de) Verfahren zum nachweis von menschlichem parvovirus-antigen
ATE349703T1 (de) Kombination von crp und d-dimer zur diagnose von tiefer venenthrombose
DE68923616T2 (de) Reduzierbare indikatoren, die pyrogallol enthalten und deren verwendung.
ATE377191T1 (de) Verfahren zur analyse von stuhlproben für diagnostische zwecke
NO20016080L (no) Analyse
ATE256704T1 (de) Antikörper und diagnostizierverfahren zur pestivirusdiagnose
FI951778A0 (fi) Menetelmä allergian toteamiseksi
WO2003107007A3 (de) Schnelltestverfahren zum nachweis von mindestens einem antigen sowie dessen verwendung
RU2021120178A (ru) Способ анализа пробы крови человека на заболевание туберкулезом путем детектирования экспрессии маркера cd154, стимулированного антигенами к возбудителям туберкулеза, в комбинации с cd38, ki-67 или hla-dr
DE69121757D1 (de) Benutzung von SP-2 monoklonalen Antikörpern zur Diagnostik und zur Beobachtung des HIV-Infektionsfortschritts
ATE251749T1 (de) Verfahren zum nachweis von mastitis
EA200000500A1 (ru) Способ испытания средства защиты на функционирование
SG152020A1 (en) Diagnostic methods
DE50208979D1 (de) Verfahren zur Erfassung der Pathogenese und/oder zur Diagnose von 'transmissiblen spongiformen Enzephalopathien'

Legal Events

Date Code Title Description
PC4A Registration of transfer of a eurasian patent by assignment
PD4A Registration of transfer of a eurasian patent in accordance with the succession in title
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AZ BY KZ KG TJ TM

MK4A Patent expired

Designated state(s): AM MD RU